Erythropoietin Therapy for Subarachnoid Hemorrhage

Completed

Phase 2 Results

Summary of Purpose

ABSTRACT: Delayed ischemic deficits (DID) and strokes caused by low cerebral blood flow (CBF) are major sources of poor outcome following aneurysmal subarachnoid hemorrhage (SAH). DID are often accompanied by vasospasm and abnormalities in cerebrovascular autoregulation, an important reflex involved in the defense against low CBF. Assessment of vasospasm and impaired autoregulation can be conveniently...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 May 2009.

1 Apr 2005 29 Aug 2005 1 Mar 2007 1 Mar 2007 1 May 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Ming-Yuan Tseng, MD MPhil MSc myt22@cam.ac.uk

    pjk21@medschl.cam.ac.uk